Research design and baseline participant characteristics of the Resilient, Empowered, Active Living with Diabetes - Telehealth (REAL-T) Study: A randomized controlled trial for young adults with type 1 diabetes.

Research design and baseline participant characteristics of the Resilient, Empowered, Active Living with Diabetes - Telehealth (REAL-T) Study: A randomized controlled trial for young adults with type 1 diabetes.
复制标题

弹性、赋权、积极的糖尿病生活 - 远程医疗 (REAL-T) 研究的研究设计和基线参与者特征:一项针对患有 1 型糖尿病的年轻人的随机对照试验。

DOI:
10.1016/j.cct.2023.107386
复制
发表时间:
2023
影响因子:
2.2
通讯作者:
Linderman,
Linderman,
中科院分区:
医学4区
文献类型:
--
作者:
Pyatak,ElizabethA;Ali,Aina;Khurana,AnyaR;Lee,Pey-Jiuan;Sideris,John;Fox,Steven;Diaz,Jesus;Granados,Gabrielle;Blanchard,Jeanine;McGuire,Riley;SalazarPlascencia,Elia;Salcedo-Rodriguez,Elizabeth;Flores-Garcia,Jaquelin;Linderman,

文献摘要

参考文献

相似文献

背景1型糖尿病(T1 D)是一种慢性疾病,影响美国近190万人。患有T1 D的年轻人(YAs)在管理他们的病情方面面临着独特的挑战,比其他年龄组的健康和福祉更差。目前的研究正在评估弹性,授权,积极生活(真实的)干预,以前显示,改善糖尿病患者的血糖水平和生活质量,使用远程医疗服务(REAL-T)扩大覆盖范围和可及性。本文报告的方法和基线参与者的REAL-T study.MethodsREAL-T的特点是一个双臂随机对照试验,招募18-30奥尔兹的T1 D通过诊所和社交媒体广告。由于COVID-19,数据收集被调整为完全远程,每三个月进行一次,为期一年。参与者接受常规护理或为期6个月的远程健康职业治疗干预。主要结果是糖化血红蛋白(A1 C);次要结果包括糖尿病困扰,生活质量,和连续血糖监测衍生measures.ResultsThe研究纳入了不同的样本209 YAs与T1 D。基线数据分析表明干预组和对照组之间的等效性。研究参与者的糖尿病痛苦明显高于类似人群,心理健康状况较差。结论REAL-T研究成功适应了COVID-19大流行期间的远程实施。通过检查长期结果,中介途径和成本效益,该研究将有助于了解针对T1 D YAs的定制干预措施的影响,旨在减少差异并改善该人群的健康和福祉。
BackgroundType 1 diabetes (T1D) is a chronic condition affecting nearly 1.9 million people in the United States. Young adults (YAs) with T1D face unique challenges in managing their condition, experiencing poorer health and well-being than other age groups. The current study is evaluating the Resilient, Empowered, Active Living (REAL) intervention, previously shown to improve glucose levels and quality of life among YAs with diabetes, using telehealth delivery (REAL-T) to expand reach and accessibility. This paper reports on the methodology and baseline participant characteristics of the REAL-T study.MethodsREAL-T is a two-arm randomized controlled trial that recruited 18–30 year olds with T1D via clinics and social media advertising. Data collection, which was adapted to be fully remote due to COVID-19, occurs every three months for one year. Participants receive either usual care or a 6-month telehealth occupational therapy intervention. The primary outcome is glycated hemoglobin (A1c); secondary outcomes include diabetes distress, quality of life, and continuous glucose monitor-derived measures.ResultsThe study enrolled a diverse sample of 209 YAs with T1D. Analysis of baseline data indicates equivalence between the intervention and control groups. Study participants have notably higher diabetes distress and poorer mental well-being than similar populations.ConclusionThe REAL-T study successfully adapted to remote implementation during the COVID-19 pandemic. By examining long-term outcomes, mediating pathways, and cost-effectiveness, the study will contribute knowledge of the impact of tailored interventions for YAs with T1D, designed to reduce disparities and improve health and well-being in this population.
HL-60-1E3,一种新型佛波二酯抗性HL-60细胞系。
DOI: --
发表时间: 1987
期刊: Cancer research
影响因子: 11.2
作者:
Leftwich,JA;Carlson,P;Adelman,B;Hall,RE
通讯作者: Hall,RE
重新审视干细胞概念:自我更新能力是造血细胞的动态特性。
DOI: --
发表时间: 1986
期刊: Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis
影响因子: --
作者:
Z. Grossman
通讯作者: Z. Grossman
分离对巨噬细胞温度敏感但对成纤维细胞转化不敏感的 MH2 逆转录病毒突变体
DOI: 10.1128/jvi.58.1.134-141.1986
发表时间: 1986
影响因子: 5.4
作者:
S. Palmieri
通讯作者: S. Palmieri
DOI: 10.1073/pnas.75.5.2458
发表时间: 1978-01-01
影响因子: 11.1
作者:
COLLINS, SJ;RUSCETTI, FW;GALLO, RC
通讯作者: GALLO, RC
c-myc 蛋白参与人体细胞 DNA 合成。
DOI: 10.1126/science.3532322
发表时间: 1986
期刊: Science
影响因子: 56.9
作者:
G. P. Studzinski;Z. Brelvi;S. C. Feldman;R. Watt
通讯作者: R. Watt